AUTL

Autolus Therapeutics
AUTL

Overview Fund Activity

119 hedge funds and large institutions have $1.12B invested in Autolus Therapeutics in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 46 increasing their positions, 26 reducing their positions, and 6 closing their positions.

Holders
119
Holders Change
+21
Holders Change %
+21.43%
% of All Funds
1.73%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.07%
New
27
Increased
46
Reduced
26
Closed
6
Calls
$1.19M
Puts
$625K
Net Calls
+$566K
Net Calls Change
-$937K

Top Buyers

1
ACA
1
Avoro Capital Advisors
New York
$78.8M
2
Wellington Management Group
2
Wellington Management Group
Massachusetts
$68.7M
3
Fidelity Investments
3
Fidelity Investments
Massachusetts
$57.5M
4
DM
4
Deerfield Management
New York
$23.2M
5
DTC
5
Deep Track Capital
Connecticut
$97.4M

Top Sellers

1
PBA
1
Paradigm Biocapital Advisors
New York
$41M
2
Adage Capital Partners
2
Adage Capital Partners
Massachusetts
$20.4M
3
TAM
3
TFG Asset Management
Cayman Islands
$48M
4
LCM
4
Lynx1 Capital Management
Puerto Rico
$8.87M
5
UOC
5
UBS O'Connor
Illinois
$994K
Name Market Value Shares Shares
Change 		Shares
Change %
SP
1
Syncona Portfolio
Guernsey
$136M 21,346,829 – –
Blackstone Inc
2
Blackstone Inc
New York
$131M 20,485,611 – –
DTC
3
Deep Track Capital
Connecticut
$97.4M 15,272,172 +3,402,875 +29%
ACA
4
Avoro Capital Advisors
New York
$78.8M 12,345,678 +12,345,678 New
Wellington Management Group
5
Wellington Management Group
Massachusetts
$68.7M 10,763,001 +10,763,001 New
Fidelity Investments
6
Fidelity Investments
Massachusetts
$57.5M 9,016,390 +9,014,165 +405,131%
TAM
7
TFG Asset Management
Cayman Islands
$48M 7,525,682 -474,318 -6%
CAM
8
Cormorant Asset Management
Massachusetts
$42.2M 6,616,667 +1,166,667 +21%
PBA
9
Paradigm Biocapital Advisors
New York
$41M 6,425,803 -6,185,532 -49%
T. Rowe Price Associates
10
T. Rowe Price Associates
Maryland
$35M 5,488,986 +2,487,778 +83%
AC
11
Armistice Capital
New York
$29.8M 4,672,000 +822,000 +21%
FLSM
12
Frazier Life Sciences Management
California
$29.5M 4,623,324 +876,467 +23%
PA
13
Perceptive Advisors
New York
$27.6M 4,330,745 +2,499,578 +137%
BlackRock
14
BlackRock
New York
$25.9M 4,055,920 +2,700,581 +199%
DM
15
Deerfield Management
New York
$23.2M 3,639,000 +3,639,000 New
AAA
16
Affinity Asset Advisors
New York
$21.5M 3,375,000 +1,824,592 +118%
Adage Capital Partners
17
Adage Capital Partners
Massachusetts
$20.4M 3,200,000 -625,532 -16%
SC
18
Stempoint Capital
New York
$18.9M 2,965,721 +2,514,346 +557%
CC
19
Commodore Capital
New York
$14.7M 2,300,000 +2,300,000 New
PL
20
Perpetual Ltd
Australia
$14.3M 2,234,515 +169,784 +8%
LCM
21
Laurion Capital Management
New York
$13.3M 2,090,471 +1,205,000 +136%
Schroder Investment Management Group
22
Schroder Investment Management Group
United Kingdom
$10.7M 1,672,732 – –
Bank of New York Mellon
23
Bank of New York Mellon
New York
$9.26M 1,450,791 +1,450,791 New
LCM
24
Lynx1 Capital Management
Puerto Rico
$8.87M 1,390,160 -468,249 -25%
FAM
25
Fred Alger Management
New York
$7.64M 1,196,876 -157,455 -12%
1
2 3 4 5